Conclusion of a non-exclusive discount agreement according to Section 130a Paragraph 8 Sgb V for medicines with the active ingredient tocilizumab (atc code: L04ac07).
Conclusion of a non-exclusive discount agreement according to § 130a paragraph 8 Sgb V for drugs with the active ingredient dabigatran etexilate (ATC code: B01ae07).